Parkinson’s disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss
Axel Chemla(University of Luxembourg), Cláudia Saraiva(University of Luxembourg), Alise Žagare(University of Luxembourg), Frida Lind‐Holm Mogensen(University of Luxembourg), Anne‐Marie Marzesco(University of Luxembourg), Kyriaki Barmpa(University of Luxembourg), Alessandro Michelucci(Luxembourg Institute of Health), Pierre Garcia(Centre Hospitalier de Luxembourg), Ginevra Sacripanti(University of Luxembourg), Jochen Ohnmacht(University of Luxembourg), Jaqueline Jung(University of Tübingen), Jens C. Schwamborn(University of Luxembourg), Vyron Gorgogietas(Université Libre de Bruxelles), Alexandre Baron(University of Luxembourg), Anne Grünewald(University of Luxembourg), Paul Antony(University of Luxembourg), Manuel Buttini(Centre Hospitalier de Luxembourg), Rejko Krüger(Centre Hospitalier de Luxembourg), Thorsten Schmidt(University of Tübingen)
Cited by 22
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
|Human Molecular Genetics|2005|566